Last update 11 Dec 2024
Recombinant human growth hormone(Changchun Genescience)
Last update 11 Dec 2024
Overview
Basic Info
Drug Type Biosimilar, Hormone |
Synonyms Recombinant Human Growth Hormone, Recombinant somatropin (Changchun Genescience), 重组人生长激素（金赛药业） + [3] |
Target |
Mechanism GHR agonists(Growth hormone receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (01 Jan 1998), |
RegulationPriority Review (CN) |
Login to view timeline
Gene Sequence
Sequence Code 26401985
The sequence is quoted from: *****
Related
11
Clinical Trials associated with Recombinant human growth hormone(Changchun Genescience)重组人生长激素注射液治疗因软骨发育不全所引起的儿童身材矮小的有效性和安全性的多中心、开放性、单臂 IV 期临床试验
[Translation] A multicenter, open-label, single-arm phase IV clinical trial of the efficacy and safety of recombinant human growth hormone injection in the treatment of short stature in children caused by achondroplasia
重组人生长激素注射液治疗肾移植前慢性肾脏疾病（CKD）引起的儿童生长障碍疗效和安全性的Ⅲ期临床试验
[Translation] Phase III clinical trial of the efficacy and safety of recombinant human growth hormone injection in the treatment of growth disorders in children caused by chronic kidney disease (CKD) before renal transplantation
重组人生长激素注射液（赛增？）治疗特发性矮小的临床试验多中心、开放、无对照、观察性研究
[Translation] Clinical trial of recombinant human growth hormone injection (Saizen?) for the treatment of idiopathic short stature: a multicenter, open, uncontrolled, observational study
100 Clinical Results associated with Recombinant human growth hormone(Changchun Genescience)
Login to view more data
100 Translational Medicine associated with Recombinant human growth hormone(Changchun Genescience)
Login to view more data
100 Patents (Medical) associated with Recombinant human growth hormone(Changchun Genescience)
Login to view more data
100 Deals associated with Recombinant human growth hormone(Changchun Genescience)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Recombinant human growth hormone(Changchun Genescience) |
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Short Stature, Idiopathic, Autosomal | CN | 04 Aug 2022 | |
| Noonan Syndrome | CN | 27 Jun 2017 | |
| Burns | CN | 01 Jan 1998 | |
| Growth Disorders | CN | 01 Jan 1998 | |
| Growth hormone deficiency | CN | 01 Jan 1998 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Prader-Willi Syndrome | NDA/BLA | CN | 15 Oct 2020 | |
| Chronic Kidney Diseases | Phase 3 | CN | 25 Jun 2018 | |
| Idiopathic short stature | Phase 3 | CN | 11 Jun 2018 | |
| Small-for-dates baby | Phase 3 | CN | 01 Dec 2014 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free